. 2020 Mar 25;23(4):101007. doi: 10.1016/j.isci.2020.101007

Table 2.

The Mean and Standard Error of the Beta-Diversity (at Different Diversity Order q = 0–3) for the Healthy and Diseased Treatments of the Three Categories (AKP, Anti-AKP, Non-AKP), Respectively, Summarized from Table S3; See the Bottom Section for the Percentages of AKP, anti-AKP, and non-AKP

Category, Treatment & Statistics			q = 0	q = 1	q = 2	q = 3
AKP	Healthy	Mean	1.646	1.584	1.635	1.674
	Healthy	Std. Err.	0.029	0.037	0.035	0.030
	Diseased	Mean	1.707	1.656	1.714	1.753
	Diseased	Std. Err.	0.028	0.033	0.029	0.025
Anti-AKP	Healthy	Mean	1.707	1.688	1.776	1.811
	Healthy	Std. Err.	0.032	0.032	0.030	0.029
	Diseased	Mean	1.641	1.620	1.707	1.731
	Diseased	Std. Err.	0.033	0.038	0.038	0.041
Non-AKP^a	Healthy	Mean	1.637	1.664	1.699	1.720
	Healthy	Std. Err.	0.067	0.044	0.043	0.042
	Diseased	Mean	1.634	1.642	1.695	1.726
	Diseased	Std. Err.	0.067	0.053	0.049	0.047
Total	Healthy	Mean	1.663	1.632	1.689	1.715
	Healthy	Std. Err.	0.024	0.024	0.023	0.022
	Diseased	Mean	1.664	1.644	1.707	1.736
	Diseased	Std. Err.	0.024	0.023	0.021	0.020
The percentage for each of the three categories (AKP, Anti-AKP, and Non-AKP), summarized fromTable S3and computed based on Wilcoxon tests of the differences between the intra-H and intra-D treatments in their beta-diversity with Hill numbers
Category			q = 0	q = 1	q = 2	q = 3
Percentage of AKP			38.1	50.0	50.0	57.1
Percentage of Anti-AKP			33.3	33.3	28.6	26.2
Percentage of Non-AKP			28.6	26.2	23.8	23.8

Table S2 contains the pairwise beta-diversity in Hill numbers for the microbiome samples of the 27 MAD case studies. Table S3was obtained from performing Wilcoxon test based on the beta-diversity listed in Table S2.